Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALCICLO: Cyclosporine Dose Adaptation for GVHD
NCT00948727Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2004
- Primary completion
- Sep 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in graft-versus-host disease (GVHD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2004; status: completed.
02
Drugs
cyclosporine
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00948727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948727.